drugset / Trial / NCT03387501
Concentrate of Autologous Rich Plasma in Growth Factors in the Treatment of the Thin Endometrium
NaSingle-groupOpen-labelTreatment
Summary
This study evaluate the percentage of women with thin endometrium who achieve an endometrial thickness equal to or greater than 7 mm after administration of PRGF (plasma rich in growth factors)
Timeline
- Start
- 2019-05-27
- Primary completion
- 2022-07-26
- Completion
- 2022-07-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PRGF-Endoret | Protein / enzyme biologic | — | Other |